|
7:30 am
|
Registration, Continental Breakfast and Visit Exhibits
|
|
8:20 am
|
Welcome and Introductions
Zeina Nahleh, MD
Cleveland Clinic Florida, Weston, Florida
|
|
8:30 am
|
Advances in Triple Negative/BRCA-Related Breast Cancer
Hatem Soliman, MD
Moffitt Cancer Center, Tampa, FL
|
|
9:00 am
|
Advances in HER2 Positive Breast Cancer
Adam M. Brufsky, MD, PhD
University of Pittsburgh, Pittsburgh, Pennsylvania
|
|
9:30 am
|
Update on Radiation and Local Therapies
Chirag Shah, MD
Cleveland Clinic, Cleveland, Ohio
|
|
10:00 am
|
Break and Visit Exhibits
|
|
10:30 am
|
Advances in Hormone Receptor-Positive Breast Cancer
Claudine Isaacs, MD
MedStar Georgetown University Hospital, Washington, DC
|
|
11:00 am
|
Case Discussions
Elizabeth Stone, MD, Moderator
Cleveland Clinic Florida, Weston, Florida
|
|
12:00 pm
|
Lunch and Visit Exhibits
|
|
1:00 pm
|
Update on Breast Cancer Prevention, Quality of Life and Survivorship Care
Banu Arun, MD
MD Anderson Cancer Center, Houston, Texas
|
|
1:30 pm
|
Biomarkers and Molecular Profiling in Breast Cancer
Thomas Budd, MD
Cleveland Clinic, Cleveland, Ohio
|
|
2:00 pm
|
Late breaking abstracts and Research in the Pipeline
Megan Kruse, MD
Cleveland Clinic, Cleveland, Ohio
|
|
2:30 pm
|
Addressing Toxicities of Novel Therapy
Erin Roesch, MD
Cleveland Clinic, Cleveland, Ohio
|
|
3:00 pm
|
Summary
Zeina Nahleh, MD
Cleveland Clinic Florida, Weston, Florida
|
|
3:15 pm
|
Adjourn
|
